In this study, we constructed a survival-related signature comprised of five immune-related lncRNAs (HCG11, MIR181A2HG, NIFK-AS1, SNHG7, and ZEB1-AS1) to predict the prognosis of CRC patients. The gene discussed is HCG11; the disease is colorectal carcinoma.